Feedback / Questions
ATI-052 - Aclaris
https://www.globenewswire.com/news-release/2025/06/23/3103239/0/en/Aclaris-Therapeutics-Initiates-Phase-1a-1b-Program-for-its-Novel-Bispecific-Antibody-ATI-052.html
Jun 23, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next